PTA Balloon Catheter Market Size, Share & Trends Analysis Report By Material Type (Polyurethane, Nylon), By Application (Peripheral Artery Disease), By End-use, By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
PTA Balloon Catheter Market Growth & Trends
The global PTA balloon catheter market size is expected t%li%reach USD 4.63 billion by 2030, registering a CAGR of 8.32% from 2024 t%li%2030, according t%li%a new report by Grand View Research, Inc. The increasing incidence of peripheral artery disorder and the rising number of Percutaneous Coronary Intervention (PCI) procedures in developing countries are key factors driving the market.
The adoption of a sedentary lifestyle by most of the population has increased the prevalence rate of various types of cardiovascular diseases worldwide. An increase in the number of cases of cardiovascular diseases across the globe is expected t%li%boost the adoption of various procedures-such as cardiac catheterizations, angioplasty, and Percutaneous Coronary Intervention (PCI)-t%li%treat such conditions, wherein PTA balloon catheters are among the essential requirements.
The COVID-19 pandemic resulted in a decline in the number of patient encounters, leading t%li%a reduction in the demand for surgical procedures, thereby impacting the industry growth. According t%li%Elsevier, the number of coronary angioplasty surgeries was 11.2% in 2020, which is lower than the previously reported data. According t%li%the National Library of Medicine, the U.S. witnessed a 52.7% decline in adult cardiac surgeries in 2020. In the later phase, as the restrictions were lifted in several countries, the volume of cardiac and peripheral surgical procedures increased. This is expected t%li%increase the demand for angioplasty surgical devices such as PTA balloon catheters.
PTA Balloon Catheter Market Report Highlights
PTA Balloon Catheter Market Growth & Trends
The global PTA balloon catheter market size is expected t%li%reach USD 4.63 billion by 2030, registering a CAGR of 8.32% from 2024 t%li%2030, according t%li%a new report by Grand View Research, Inc. The increasing incidence of peripheral artery disorder and the rising number of Percutaneous Coronary Intervention (PCI) procedures in developing countries are key factors driving the market.
The adoption of a sedentary lifestyle by most of the population has increased the prevalence rate of various types of cardiovascular diseases worldwide. An increase in the number of cases of cardiovascular diseases across the globe is expected t%li%boost the adoption of various procedures-such as cardiac catheterizations, angioplasty, and Percutaneous Coronary Intervention (PCI)-t%li%treat such conditions, wherein PTA balloon catheters are among the essential requirements.
The COVID-19 pandemic resulted in a decline in the number of patient encounters, leading t%li%a reduction in the demand for surgical procedures, thereby impacting the industry growth. According t%li%Elsevier, the number of coronary angioplasty surgeries was 11.2% in 2020, which is lower than the previously reported data. According t%li%the National Library of Medicine, the U.S. witnessed a 52.7% decline in adult cardiac surgeries in 2020. In the later phase, as the restrictions were lifted in several countries, the volume of cardiac and peripheral surgical procedures increased. This is expected t%li%increase the demand for angioplasty surgical devices such as PTA balloon catheters.
PTA Balloon Catheter Market Report Highlights
- North America market dominated with a share of 47.95% in 2023. This can be attributed t%li%the higher product availability, high demand for surgical procedures, and better awareness in the region
- Asia Pacific is expected t%li%exhibit the fastest growth rate during the forecast period due t%li%government initiatives and increasing incidence of target disorders
- Supportive government regulations t%li%commercialize medical devices in Latin America are expected t%li%impel industry growth. For instance, most Latin American countries only require the U.S. FDA or CE mark approval for filing marketing approvals
- Incorporation of the latest health technologies, partnerships and collaborations, product expansion, and mergers & acquisitions are some of the strategies being adopted by key players t%li%gain a competitive edge in the market. For instance, in February 2022, Boston Scientific Corporation acquired Baylis Medical Company, Inc., a medical device company primarily providing solutions t%li%support catheter-based left heart procedures
- The shortage of cardiac surgeons worldwide is a big concern. Low-income countries are facing this issue more severely. For instance, North Africa has only one surgeon per 1.1 million people. This is resulting in restricting the number of surgeries that could be performed, hindering industry growth
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Material Type
1.2.2. Application
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecast timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity price analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Material Type Segment
2.2.2. Application Segment
2.2.3. End Use Segment.
2.2.4. Regional Outlook
2.3. Competitive Insights
CHAPTER 3. GLOBAL PTA BALLOON CATHETER MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing Prevalence of Cardiovascular Diseases
3.2.1.2. Growing Adoption of Minimally Invasive Procedures
3.2.2. Market restraint analysis
3.2.2.1. Potential Complications Associated with Angioplasty Procedures
3.2.2.2. Stringent Regulatory Policies
3.3. PTA Balloon Catheter Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. PTA BALLOON CATHETER MARKET: MATERIAL TYPE ESTIMATES & TREND ANALYSIS
4.1. PTA Balloon Catheter Market: Material Type Dashboard
4.2. PTA Balloon Catheter Market: Material Type Movement Analysis
4.3. PTA Balloon Catheter Market Size & Forecasts and Trend Analysis, by Material Type, 2018 to 2030 (USD Million)
4.4. Nylon
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Polyurethane
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.6. Others
4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 5. PTA BALLOON CATHETER MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. PTA Balloon Catheter Market: Application Dashboard
5.2. PTA Balloon Catheter Market: Application Movement Analysis
5.3. PTA Balloon Catheter Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Peripheral Artery Disease
5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Coronary Artery Disease
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 6. PTA BALLOON CATHETER MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. PTA Balloon Catheter Market: End Use Dashboard
6.2. PTA Balloon Catheter Market: End Use Movement Analysis
6.3. PTA Balloon Catheter Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals
6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5. Ambulatory Surgical Centers
6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.6. Others
6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 7. PTA BALLOON CATHETER MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY COUNTRY, MATERIAL TYPE, APPLICATION, & END USE
7.1. Global PTA Balloon Catheter Market: Regional Dashboard
7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
7.3. North America
7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.3.2. U.S.
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
7.3.3. Canada
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/ reimbursement structure
7.3.3.3. Competitive scenario
7.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
7.3.4. Mexico
7.3.4.1. Key country dynamics
7.3.4.2. Regulatory framework/ reimbursement structure
7.3.4.3. Competitive scenario
7.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
7.4. Europe
7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.4.2. UK
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
7.4.3. Germany
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
7.4.4. France
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
7.4.5. Italy
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
7.4.6. Spain
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
7.4.8. Norway
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
7.4.9. Denmark
7.4.9.1. Key country dynamics
7.4.9.2. Regulatory framework/ reimbursement structure
7.4.9.3. Competitive scenario
7.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3. Japan
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4. India
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
7.5.5. Australia
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
7.5.7. South Korea
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework/ reimbursement structure
7.5.7.3. Competitive scenario
7.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
7.6. Latin America
7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6.2. Brazil
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
7.6.3. Argentina
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
7.7. MEA
7.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
7.7.3. South Africa
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
7.7.4. UAE
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework/ reimbursement structure
7.7.5.3. Competitive scenario
7.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Manufacturers
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Medtronic
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Application benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Tuermo Corporation
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Application benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Cardinal Health
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Application benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Boston Scientific Corporation.
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Application benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Natec Medical
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Application benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Cook Medical
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Application benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Biotronik
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Application benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Surmodics, Inc.
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Application benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Andratec
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Application benchmarking
8.3.12.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Material Type
1.2.2. Application
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecast timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity price analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Material Type Segment
2.2.2. Application Segment
2.2.3. End Use Segment.
2.2.4. Regional Outlook
2.3. Competitive Insights
CHAPTER 3. GLOBAL PTA BALLOON CATHETER MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing Prevalence of Cardiovascular Diseases
3.2.1.2. Growing Adoption of Minimally Invasive Procedures
3.2.2. Market restraint analysis
3.2.2.1. Potential Complications Associated with Angioplasty Procedures
3.2.2.2. Stringent Regulatory Policies
3.3. PTA Balloon Catheter Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. PTA BALLOON CATHETER MARKET: MATERIAL TYPE ESTIMATES & TREND ANALYSIS
4.1. PTA Balloon Catheter Market: Material Type Dashboard
4.2. PTA Balloon Catheter Market: Material Type Movement Analysis
4.3. PTA Balloon Catheter Market Size & Forecasts and Trend Analysis, by Material Type, 2018 to 2030 (USD Million)
4.4. Nylon
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Polyurethane
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.6. Others
4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 5. PTA BALLOON CATHETER MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. PTA Balloon Catheter Market: Application Dashboard
5.2. PTA Balloon Catheter Market: Application Movement Analysis
5.3. PTA Balloon Catheter Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Peripheral Artery Disease
5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Coronary Artery Disease
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 6. PTA BALLOON CATHETER MARKET: END USE ESTIMATES & TREND ANALYSIS
6.1. PTA Balloon Catheter Market: End Use Dashboard
6.2. PTA Balloon Catheter Market: End Use Movement Analysis
6.3. PTA Balloon Catheter Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals
6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5. Ambulatory Surgical Centers
6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.6. Others
6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 7. PTA BALLOON CATHETER MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY COUNTRY, MATERIAL TYPE, APPLICATION, & END USE
7.1. Global PTA Balloon Catheter Market: Regional Dashboard
7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
7.3. North America
7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.3.2. U.S.
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
7.3.3. Canada
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/ reimbursement structure
7.3.3.3. Competitive scenario
7.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
7.3.4. Mexico
7.3.4.1. Key country dynamics
7.3.4.2. Regulatory framework/ reimbursement structure
7.3.4.3. Competitive scenario
7.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
7.4. Europe
7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.4.2. UK
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
7.4.3. Germany
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
7.4.4. France
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
7.4.5. Italy
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
7.4.6. Spain
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
7.4.8. Norway
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
7.4.9. Denmark
7.4.9.1. Key country dynamics
7.4.9.2. Regulatory framework/ reimbursement structure
7.4.9.3. Competitive scenario
7.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3. Japan
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
7.5.4. India
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
7.5.5. Australia
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
7.5.7. South Korea
7.5.7.1. Key country dynamics
7.5.7.2. Regulatory framework/ reimbursement structure
7.5.7.3. Competitive scenario
7.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
7.6. Latin America
7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.6.2. Brazil
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
7.6.3. Argentina
7.6.3.1. Key country dynamics
7.6.3.2. Regulatory framework/ reimbursement structure
7.6.3.3. Competitive scenario
7.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
7.7. MEA
7.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
7.7.3. South Africa
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
7.7.4. UAE
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
7.7.5. Kuwait
7.7.5.1. Key country dynamics
7.7.5.2. Regulatory framework/ reimbursement structure
7.7.5.3. Competitive scenario
7.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Manufacturers
8.2. Company/Competition Categorization
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2023
8.3.4. Medtronic
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Application benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Tuermo Corporation
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Application benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Cardinal Health
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Application benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Boston Scientific Corporation.
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Application benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Natec Medical
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Application benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Cook Medical
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Application benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Biotronik
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Application benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Surmodics, Inc.
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Application benchmarking
8.3.11.4. Strategic initiatives
8.3.12. Andratec
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Application benchmarking
8.3.12.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviations
Table 2 List of secondary sources
Table 1 List of abbreviations
Table 2 List of secondary sources
LIST OF FIGURES
Fig. 1 South Korea botulinum toxin type A market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 South Korea botulinum toxin type a market revenues, 2023 (USD Millions)
Fig. 9 Market driver relevance analysis (Current & future impact)
Fig. 10 Market restraint relevance analysis (Current & future impact)
Fig. 11 Porter’s five forces analysis
Fig. 12 PESTLE analysis
Fig. 13 South Korea botulinum toxin type A market: application outlook
Fig. 16 South Korea upper face market, 2018 - 2030 (USD Million)
Fig. 16 South Korea glabellar wrinkles market, 2018 - 2030 (USD Million)
Fig. 16 South Korea forehead wrinkles market, 2018 - 2030 (USD Million)
Fig. 16 South Korea crow’s feet market, 2018 - 2030 (USD Million)
Fig. 16 South Korea mid face market, 2018 - 2030 (USD Million)
Fig. 16 South Korea lower face market, 2018 - 2030 (USD Million)
Fig. 16 South Korea body market, 2018 - 2030 (USD Million)
Fig. 14 South Korea botulinum toxin type A market: gender movement analysis
Fig. 16 South Korea female market, 2018 - 2030 (USD Million)
Fig. 16 South Korea male market, 2018 - 2030 (USD Million)
Fig. 13 South Korea botulinum toxin type A market: age outlook
Fig. 16 South Korea below 30 years market, 2018 - 2030 (USD Million)
Fig. 16 South Korea 31 to 59 years market, 2018 - 2030 (USD Million)
Fig. 16 South Korea over 60 years market, 2018 - 2030 (USD Million)
Fig. 14 South Korea botulinum toxin type A market: end-use movement analysis
Fig. 16 South Korea hospitals market, 2018 - 2030 (USD Million)
Fig. 16 South Korea specialty clinics & aesthetic centers market, 2018 - 2030 (USD Million)
Fig. 16 South Korea medspas market, 2018 - 2030 (USD Million)
Fig. 15 Segment dashboard
Fig. 45 Market participant categorization
Fig. 46 Strategy mapping
Fig. 1 South Korea botulinum toxin type A market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 South Korea botulinum toxin type a market revenues, 2023 (USD Millions)
Fig. 9 Market driver relevance analysis (Current & future impact)
Fig. 10 Market restraint relevance analysis (Current & future impact)
Fig. 11 Porter’s five forces analysis
Fig. 12 PESTLE analysis
Fig. 13 South Korea botulinum toxin type A market: application outlook
Fig. 16 South Korea upper face market, 2018 - 2030 (USD Million)
Fig. 16 South Korea glabellar wrinkles market, 2018 - 2030 (USD Million)
Fig. 16 South Korea forehead wrinkles market, 2018 - 2030 (USD Million)
Fig. 16 South Korea crow’s feet market, 2018 - 2030 (USD Million)
Fig. 16 South Korea mid face market, 2018 - 2030 (USD Million)
Fig. 16 South Korea lower face market, 2018 - 2030 (USD Million)
Fig. 16 South Korea body market, 2018 - 2030 (USD Million)
Fig. 14 South Korea botulinum toxin type A market: gender movement analysis
Fig. 16 South Korea female market, 2018 - 2030 (USD Million)
Fig. 16 South Korea male market, 2018 - 2030 (USD Million)
Fig. 13 South Korea botulinum toxin type A market: age outlook
Fig. 16 South Korea below 30 years market, 2018 - 2030 (USD Million)
Fig. 16 South Korea 31 to 59 years market, 2018 - 2030 (USD Million)
Fig. 16 South Korea over 60 years market, 2018 - 2030 (USD Million)
Fig. 14 South Korea botulinum toxin type A market: end-use movement analysis
Fig. 16 South Korea hospitals market, 2018 - 2030 (USD Million)
Fig. 16 South Korea specialty clinics & aesthetic centers market, 2018 - 2030 (USD Million)
Fig. 16 South Korea medspas market, 2018 - 2030 (USD Million)
Fig. 15 Segment dashboard
Fig. 45 Market participant categorization
Fig. 46 Strategy mapping
